ArticleBiotechnology letters2025
Application of aurintricarboxylic acid to boost CHO cell performance.
Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCurrently, a robust process using healthy Chinese hamster ovary (CHO) cells, the dominating host for biopharmaceutical protein therapeutics, is crucial for high productivity and successful scaling-up. However, issues which are originated from cell performance and detrimental to protein products such as dramatic viability drop and accumulation of toxic metabolites still exist. Aurintricarboxylic acid (ATA), reported as an antioxidant chelator to prevent apoptosis and boost cell growth, was applied as an additive in this study to address the above problems.
methodsTwo CHO cells were cultivated by fed-batch culture with ATA of different concentrations and adding strategies supplemented. The reactive oxygen species (ROS) test and confocal microscopy have been used to illustrate the working mechanism of ATA.
resultsATA was proved to be effective in maintaining viability and improving lactate performance in the late fed-batch culture stage for both tested clones. Briefly, the harvest viability was increased by at least 10% after ATA was introduced, and the suppression of lactate accumulation was observed with ATA addition. Moreover, besides adding ATA in the fed-batch stage, a novel and favorable process to involve ATA in seed train was developed, which improved the performance of seed and further benefitted the cell performance and productivity during fed-batch culture. And the ATA was detected to penetrate into CHO cells and suppress the ROS generation intracellularly.
conclusionOverall, this study advances current knowledge with respect to ATA's capability of enhancing cell performances for CHO cell manufacturing and introduces a novel process of hyper seed train.
Indexed as
Identifiers
40696242What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.